Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Talc Claimants Argue J&J’s Second Bankruptcy Filing Not Brought in Good Faith in Motion to Dismiss Johnson & Johnson’s LTL Management subsidiary still cannot show it faces the financial distress necessary for such a bankruptcy filing, talc claimants argue April 26, 2023 Irvin Jackson Add Your Comments In response to a second attempt by Johnson & Johnson’s LTL Management subsidiary to force talcum powder lawsuits through the U.S. bankruptcy system, a group of talc claimants have filed a motion to dismiss the latest filing, indicating it was not done in good faith and is just another scheme to avoid paying women diagnosed with ovarian cancer and other injuries the damages they are entitled to receive. The pharmaceutical company faces nearly 40,000 Johnson’s Baby Powder lawsuits and Shower-to-Shower lawsuits brought by women nationwide, each alleging asbestos particles in the talc products caused them to develop ovarian cancer, mesothelioma, and other injuries. Last year, following a series of massive jury verdicts returned in early trials, Johnson & Johnson attempted a controversial bankruptcy scheme by transferring all liability it faced from talc claimants to a newly created subsidiary, LTL Management, LLC, which immediately filed for bankruptcy. Following a prior motion to dismiss filed by claimants and a number of public interest groups, the U.S. Court of Appeals for the Third Circuit rejected that bankruptcy earlier this year, finding that the LTL subsidiary did not face any real financial distress, since Johnson & Johnson has billions of assets on hand. The decision set the stage for talc claimants to move forward with their cases through the U.S. court system, and a series of trials were expected to begin in the coming months. Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Rather than negotiating in good faith or defending the safety of their talc products at trial, Johnson & Johnson made the controversial decision to refile the LTL bankruptcy only days later, and proposed an $8.9 billion talc settlement, which would require resolution of all current and future claims through the U.S. bankruptcy system. Talc Claimants File Motion to Dismiss J&J’s Bankruptcy Plan The latest talc settlement plan immediately came under heavy fire from attorneys representing talc claimants, and was rejected by the entire Plaintiffs’ Steering Committee, which represents the interests of all plaintiffs pursuing claims in the federal court system, where the litigation is centralized before U.S. District Judge Michael Shipp in the U.S. District Court for the District of New Jersey. Leading talc attorneys maintain that the settlement amount proposed is inadequate, and filed a motion to dismiss LTL’s bankruptcy filing (PDF) on April 23. The filing notes that the first bankruptcy attempt was rejected by the Third Circuit, arguing that the filing was not done in good faith, since LTL Management still faces no real financial distress. In the filing to dismiss this second bankruptcy plan, talc claimants note that LTL Management’s financial position has not changed, and indicate that this latest filing is nothing more than a further attempt to delay the litigation and deprive women of their day in court. “After weeks of planning this second bankruptcy, after days of depositions, and after hours of examination of LTL’s primary corporate witness, what has LTL actually established? That it has long-term contingent and unliquidated liability—which it is unable to calculate—and that it has sufficient funds to meet that liability,” the motion states. “Despite every opportunity, LTL failed to present to this Court even the most summary evidence that it cannot meet its liabilities as they come due for the foreseeable future.” The plaintiffs argue that in the latest filing, LTL “feigns” financial distress by suggesting it could face financial troubles in a hypothetical future scenario, which the motion claims is an attempt at abusing the bankruptcy system for a second time. In a statement (PDF) issued on April 24, Erik Haas, Worldwide Vice President of Litigation at Johnson & Johnson, claimed the dismissal motion was an attempt to prevent all talc claimants from voting on the settlement plan. However, plaintiffs’ attorneys say only a small number of law firms have come forward in support of the deal, and members of the plaintiffs’ steering committee point out that many of those firms do not even represent clients with filed cases in the federal court system. Therefore, the talc claimants argue that the litigation should not be delayed by any attempt to push this inadequate settlement offer. May 2023 Talcum Powder Lawsuit Update As part of the second bankruptcy filing, LTL Management called for an extension of a prior stay on all talc powder litigation in the U.S., which was set to be lifted after the appeals court rejected the first bankruptcy attempt. Last week, U.S. Bankruptcy Judge Michael Kaplan agreed to pause any new trials over talcum powder injury claims for only 60 days, as he expressed skepticism about the latest filing. However, he did allow plaintiffs to file new lawsuits during that time. Judge Kaplan also made it clear that attorneys representing talcum powder cancer lawsuit plaintiffs with pending trials can keep preparing those cases during the 60-day time period, which may allow trials to resume promptly if this second Johnson & Johnson bankruptcy filing is also rejected. Johnson & Johnson has already spent $1 billion defending the litigation, on top of Baby Powder settlements and verdicts which have amounted to another $3.5 billion, according to the original bankruptcy filing. Prior estimates suggested Johnson & Johnson would need to pay more than $10 billion to resolve all lawsuits involving cancer caused by their products. However, that was before the company failed in its initial attempt to resolve the claims through bankruptcy. With the size of the litigation continuing to grow, and the company facing the prospect of more individual talcum powder lawsuit payouts that may be awarded in the coming months, lawyers maintain that the total cost to settle all talcum powder lawsuits now requires substantially more funds than the company is proposing. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Asbestos, Baby Powder, Bankruptcy, Cancer, Johnson & Johnson, Ovarian Cancer, Shower to Shower, Supreme Court, Talcum Powder More Talcum Powder Lawsuit Stories $1.5B Talcum Powder Verdict Returned by Baltimore Jury, In Latest Blow to J&J December 23, 2025 J&J Hit With Another $65M Verdict in Lawsuit Over Baby Powder Cancer Risks December 22, 2025 $40M Verdict Returned in Talcum Powder Lawsuit Brought by Two Women With Ovarian Cancer December 15, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES First Uber Driver Sexual Assault Bellwether Trial Will Move Forward as Planned: Court (Posted: today) A motion to delay the first Uber driver sexual assault bellwether trial was rejected by a federal judge, allowing the case to move forward to a jury beginning January 13. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJPML To Consider MDL for Lyft Passenger Sexual Assault Lawsuits Filed in Federal Courts on Jan. 29 (01/06/2026)Uber Seeks To Delay Passenger Sexual Assault Lawsuit From Going Before Jury in Jan. 2026 (12/31/2025)Tinder and Hinge Lawsuit Claims Women Were Drugged, Raped by a Known Sexual Predator (12/18/2025) Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (Posted: yesterday) A Depo-Provera lawsuit claims the birth control injections led a woman to develop multiple brain tumors which needed repeated surgeries to address. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025) Presentations on How Hair Relaxers Cause Cancer Will Be Heard by MDL Judge This Week (Posted: 2 days ago) A federal judge will receive presentations this week on how hair relaxers cause cancer and other important scientific points in the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep (12/10/2025)Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (11/13/2025)Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)
$40M Verdict Returned in Talcum Powder Lawsuit Brought by Two Women With Ovarian Cancer December 15, 2025
First Uber Driver Sexual Assault Bellwether Trial Will Move Forward as Planned: Court (Posted: today) A motion to delay the first Uber driver sexual assault bellwether trial was rejected by a federal judge, allowing the case to move forward to a jury beginning January 13. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJPML To Consider MDL for Lyft Passenger Sexual Assault Lawsuits Filed in Federal Courts on Jan. 29 (01/06/2026)Uber Seeks To Delay Passenger Sexual Assault Lawsuit From Going Before Jury in Jan. 2026 (12/31/2025)Tinder and Hinge Lawsuit Claims Women Were Drugged, Raped by a Known Sexual Predator (12/18/2025)
Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (Posted: yesterday) A Depo-Provera lawsuit claims the birth control injections led a woman to develop multiple brain tumors which needed repeated surgeries to address. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)
Presentations on How Hair Relaxers Cause Cancer Will Be Heard by MDL Judge This Week (Posted: 2 days ago) A federal judge will receive presentations this week on how hair relaxers cause cancer and other important scientific points in the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep (12/10/2025)Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (11/13/2025)Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)